Found: 51
Select item for more details and to access through your institution.
Effects of a α<sub>2C</sub>-Adrenoreceptor Gene Polymorphism on Neural Responses to Facial Expressions in Depression.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 8, p. 1750, doi. 10.1038/sj.npp.1301010
- By:
- Publication type:
- Article
Altered 5-HT<sub>2A</sub> Receptor Binding after Recovery from Bulimia-Type Anorexia Nervosa: Relationships to Harm Avoidance and Drive for Thinness.
- Published in:
- Neuropsychopharmacology, 2004, v. 29, n. 6, p. 1143, doi. 10.1038/sj.npp.1300430
- By:
- Publication type:
- Article
Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Association of In Vivo k-Opioid Receptor Availability and the Transdiagnostic Dimensional Expression of Trauma-Related Psychopathology.
- Published in:
- JAMA Psychiatry, 2014, v. 71, n. 11, p. 1262, doi. 10.1001/jamapsychiatry.2014.1221
- By:
- Publication type:
- Article
Association of Posttraumatic Stress Disorder With Reduced In Vivo Norepinephrine Transporter Availability in the Locus Coeruleus.
- Published in:
- JAMA Psychiatry, 2013, v. 70, n. 11, p. 1199, doi. 10.1001/jamapsychiatry.2013.399
- By:
- Publication type:
- Article
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 2, p. 164, doi. 10.1177/02698811221140008
- By:
- Publication type:
- Article
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 11, p. 2519, doi. 10.1038/npp.2014.110
- By:
- Publication type:
- Article
Serotonin transporter binding after recovery from eating disorders.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Serotonin transporter binding after recovery from eating disorders.
- Published in:
- Psychopharmacology, 2007, v. 195, n. 3, p. 315, doi. 10.1007/s00213-007-0896-7
- By:
- Publication type:
- Article
Performance Characteristics of the Neuro EXPLORER, a Next-Generation Human Brain PET/CT Imager.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.124.267767
- By:
- Publication type:
- Article
First-in-Human Study of <sup>18</sup>F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266470
- By:
- Publication type:
- Article
First-in-Human Study of <sup>18</sup>F-SynVesT-2: An SV2A PET Imaging Probe with Fast Brain Kinetics and High Specific Binding.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 462, doi. 10.2967/jnumed.123.266470
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
Imaging pituitary vasopressin 1B receptor in humans with the novel PET radiotracer <sup>11</sup>C-TASP699.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262430
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.249144
- By:
- Publication type:
- Article
First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer <sup>11</sup>C-LSN3172176.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.246967
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.249144
- By:
- Publication type:
- Article
First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer <sup>11</sup>C-LSN3172176.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.246967
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.249144
- By:
- Publication type:
- Article
First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer <sup>11</sup>C-LSN3172176.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.246967
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of 11C-EKAP and 11CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
First-in-human evaluation of <sup>18</sup>F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.249144
- By:
- Publication type:
- Article
First in Human Assessment of the Novel M1 Muscarinic Acetylcholine Receptor PET Radiotracer <sup>11</sup>C-LSN3172176.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.246967
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
Kinetic modeling and test-retest reproducibility of <sup>11</sup>C-EKAP and <sup>11</sup>CFEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.227694
- By:
- Publication type:
- Article
MAGING THE ENZYME 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 WITH POSITRON EMISSION TOMOGRAPHY: EVALUATION OF THE NOVEL RADIOTRACER 11C-AS2471907 IN HUMAN BRAIN.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.219766
- By:
- Publication type:
- Article
Imaging the Enzyme 11b-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer <sup>11</sup>C-AS2471907 in Human Brain.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 8, p. 1140, doi. 10.2967/jnumed.118.219766
- By:
- Publication type:
- Article
Age-Related Change in 5-HT<sub>6</sub> Receptor Availability in Healthy Male Volunteers Measured with <sup> 11</sup>C-GSK215083 PET.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1445, doi. 10.2967/jnumed.117.206516
- By:
- Publication type:
- Article
Test-Retest Reproducibility of Binding Parameters in Humans with <sup>11</sup>C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 243, doi. 10.2967/jnumed.114.147975
- By:
- Publication type:
- Article
Age Effects on Serotonin Receptor 1B as Assessed by PET.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1411, doi. 10.2967/jnumed.112.103598
- By:
- Publication type:
- Article
Kinetic evaluation and test–retest reproducibility of [<sup>11</sup>C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2018, v. 38, n. 11, p. 2041, doi. 10.1177/0271678X17724947
- By:
- Publication type:
- Article
Personality traits after recovery from eating disorders: Do subtypes differ?
- Published in:
- International Journal of Eating Disorders, 2006, v. 39, n. 4, p. 276, doi. 10.1002/eat.20251
- By:
- Publication type:
- Article
Neurobiology of Anorexia Nervosa: Clinical Implications of Alterations of the Function of Serotonin and Other Neuronal Systems.
- Published in:
- International Journal of Eating Disorders, 2005, v. 37, p. 15, doi. 10.1002/eat.20109
- By:
- Publication type:
- Article
Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1327, doi. 10.1007/s00259-020-05149-3
- By:
- Publication type:
- Article
PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[<sup>11</sup>C]O-methylreboxetine and HRRT.
- Published in:
- Synapse, 2010, v. 64, n. 1, p. 30, doi. 10.1002/syn.20696
- By:
- Publication type:
- Article
Synaptic loss and its association with symptom severity in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00655-9
- By:
- Publication type:
- Article
Author Correction: Synaptic loss and its association with symptom severity in Parkinson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers.
- Published in:
- Epilepsia (Series 4), 2019, v. 60, n. 5, p. 958, doi. 10.1111/epi.14701
- By:
- Publication type:
- Article
Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00944-5
- By:
- Publication type:
- Article
Reduced ventral striatal/ventral pallidal serotonin receptor binding potential in major depressive disorder.
- Published in:
- Psychopharmacology, 2011, v. 213, n. 2/3, p. 547, doi. 10.1007/s00213-010-1881-0
- By:
- Publication type:
- Article
Imaging the cannabinoid CB1 receptor in humans with [<sup>11</sup>C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2015, v. 35, n. 8, p. 1313, doi. 10.1038/jcbfm.2015.46
- By:
- Publication type:
- Article